Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
About this item
Full title
Author / Creator
Sablerolles, Roos S.G. , Rietdijk, Wim J.R. , Goorhuis, Abraham , Postma, Douwe F. , Visser, Leo G. , Geers, Daryl , Schmitz, Katharina S. , Garcia Garrido, Hannah M. , Koopmans, Marion P.G. , Dalm, Virgil A.S.H. , Kootstra, Neeltje A. , Huckriede, Anke L.W. , Lafeber, Melvin , van Baarle, Debbie , GeurtsvanKessel, Corine H. , de Vries, Rory D. , van der Kuy, P. Hugo M. and SWITCH Research Group
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
A trial involving 434 participants examined the effects of no boosting or of boosting with one of the three approved Covid-19 vaccines — Ad26.COV2.S, mRNA-1273, or BNT162b2 — 3 months after the primary vaccination. All the vaccines increased neutralizing-antibody levels and T-cell responses, but the increases with the mRNA vaccines were higher.
Alternative Titles
Full title
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
Authors, Artists and Contributors
Author / Creator
Rietdijk, Wim J.R.
Goorhuis, Abraham
Postma, Douwe F.
Visser, Leo G.
Geers, Daryl
Schmitz, Katharina S.
Garcia Garrido, Hannah M.
Koopmans, Marion P.G.
Dalm, Virgil A.S.H.
Kootstra, Neeltje A.
Huckriede, Anke L.W.
Lafeber, Melvin
van Baarle, Debbie
GeurtsvanKessel, Corine H.
de Vries, Rory D.
van der Kuy, P. Hugo M.
SWITCH Research Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8796791
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8796791
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2116747
